The Valley Desk

NCT06134232 · Interventional trial

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

Overall registry status Recruiting

Phase 2

Conditions Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov